Johnson & Johnson stock (NYSE: JNJ) lost about 7% in 2024, underperforming the broader S&P 500 index, which gained 23% for ...
Southfield-based PharmaCo Inc. — a cannabis company linked to a bribery scheme to Michigan’s then-top marijuana regulator ...
United States Steel Corp. is losing one of the members of its board of directors. Jeh C. Johnson, U.S. Homeland Security ...
Johnson & Johnson shares are down 3% Wednesday on safety concerns that could dim sales prospects for a new heart device, ...
The Netflix documentary ‘Don’t Die’ follows a tech millionaire’s quest to live forever. Here’s everything to know about Bryan ...
Dwayne Johnson now holds a greater stake in WWE, the place where his journey began. As AFROTECHâ„¢ previously reported, the ...
Wells Fargo analyst Larry Biegelsen maintained a Hold rating on Johnson & Johnson (JNJ – Research Report) yesterday and set a price target ...
JNJ has an attractive 3.41% dividend yield comparable to the yield on long-term bonds. Given the lack of price movement and ...
The Man Who Wants to Live Forever introduced many viewers to the Minicircle company, and here's what the organization ...
Johnson & Johnson closed $22.62 below its 52-week high ($168.85), which the company achieved on September 4th.
RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Johnson & Johnson (JNJ – Research Report) on January 6 and set a price ...
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments ...